Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction

Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2277-87. doi: 10.1152/ajpheart.00142.2002.

Abstract

The activities of cardiac protein kinase C (PKC) were examined in hemodynamically assessed rats subsequent to myocardial infarction (MI). Both Ca(2+)-dependent and Ca(2+)-independent PKC activities increased significantly in left ventricular (LV) and right ventricular (RV) homogenates at 1, 2, 4, and 8 wk after MI was induced. PKC activities were also increased in both LV and RV cytosolic and particulate fractions from 8-wk infarcted rats. The relative protein contents of PKC-alpha, -beta, -epsilon, and -zeta isozymes were significantly increased in LV homogenate, cytosolic (except PKC-alpha), and particulate fractions from the failing rats. On the other hand, the protein contents of PKC-alpha, -beta, and -epsilon isozymes, unlike the PKC-zeta isozyme, were increased in RV homogenate and cytosolic fractions, whereas the RV particulate fraction showed an increase in the PKC-alpha isozyme only. These changes in the LV and RV PKC activities and protein contents in the 8-wk infarcted animals were partially corrected by treatment with the angiotensin-converting enzyme inhibitor imidapril. No changes in protein kinase A activity and its protein content were seen in the 8-wk infarcted hearts. The results suggest that the increased PKC activity in cardiac dysfunction due to MI may be associated with an increase in the expression of PKC-alpha, -beta, and -epsilon isozymes, and the improvement of heart function in the infarcted animals by imidapril may be due to partial prevention of changes in PKC activity and isozyme contents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cytosol / enzymology
  • Cytosol / metabolism
  • Heart Failure / enzymology*
  • Heart Failure / etiology
  • Heart Ventricles / drug effects
  • Heart Ventricles / enzymology
  • Hemodynamics / drug effects
  • Hemodynamics / physiology
  • Imidazoles / pharmacology
  • Imidazolidines*
  • Immunoblotting
  • Isoenzymes / biosynthesis
  • Male
  • Myocardial Infarction / complications*
  • Myocardium / enzymology
  • Protein Kinase C / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Imidazoles
  • Imidazolidines
  • Isoenzymes
  • imidapril
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C